Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Biliary Tract Neoplasms × pamiparib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Ovarian Neoplasms 5 Glioblastoma 4 Neoplasms 2 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Solid Tumors 1 Solid Tumor 1 Rare Tumour 1 Neuroectodermal Tumors 1 Nervous System Diseases 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Neoadjuvant Therapy 1 Metastatic Castration-resistant Prostate Cancer 1 Metastatic Castration-Resistant Prostate Cancer (mCRPC) 1 Locally Advanced Prostate Cancer 1 Limited Stage Small Cell Lung Cancer 1 Hereditary leiomyomatosis and renal cell cancer 1 HER2-negative Breast Cancer 1 Gliosarcoma 1 Glioma 1 For Participants With Advanced Solid Tumors Failed With Previous Lines of Treatment 1 Central Nervous System Neoplasms 1 Carcinosarcoma 1 Carcinoma, Renal Cell 1 Carcinoma, Ovarian Epithelial 1 Brain Neoplasms 1 Biliary Tract Neoplasms 1 Astrocytoma 1 Advanced Malignant Solid Neoplasm 1

Interventions

Gemcitabine 75 Cisplatin 60 Capecitabine 31 Oxaliplatin 29 durvalumab 24 Fluorouracil 21 pembrolizumab 19 Leucovorin 19 S 1 (combination) 13 Irinotecan 11 lenvatinib 9 Nivolumab 9 Bevacizumab 8 tremelimumab 7 Injections 7 130-nm albumin-bound paclitaxel 7 apatinib 6 Trastuzumab 6 Docetaxel 6 surufatinib 5 camrelizumab 5 Immune Checkpoint Inhibitors 5 Carboplatin 5 Albumin-Bound Paclitaxel 5 titanium silicide 4 irinotecan sucrosofate 4 gemcitabine-oxaliplatin regimen 4 envafolimab 4 Folfox protocol 4 Drug Therapy 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04796454 2022-06-01

PAMICC

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Withdrawn

Gastrointestinal

Biliary Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡